(Q39389959)

11 September 2017

title

Targeted etanercept for treatment-refractory pain due to bone metastasis: two case reports (English)

1 reference

11 September 2017

Targeted etanercept for treatment-refractory pain due to bone metastasis: Two case reports (English)

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(03)80219-9

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(03)80219-9

14 March 2024

author

Edward Lewis Tobinick

1

object named as

Edward Lewis Tobinick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512134

14 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14512134

14 March 2024

publication date

1 August 2003

1 reference

full work available at URL

11 September 2017

https://api.elsevier.com/content/article/PII:S0149291803802199?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(03)80219-9

https://api.elsevier.com/content/article/PII:S0149291803802199?httpAccept=text/plain

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(03)80219-9

14 March 2024

published in

Clinical Therapeutics

1 reference

11 September 2017

volume

25

1 reference

11 September 2017

issue

8

1 reference

11 September 2017

page(s)

2279-2288

1 reference

Bone metastases: approaches to management

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Osteolytic bone metastasis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Localized, tumor-associated osteolysis involves the recruitment and activation of osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Human breast-cancer cells stimulate the fusion, migration and resorptive activity of osteoclasts in bone explants

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Mechanisms of osteolytic bone metastases in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Osteoclast-mediated osteolysis in bone metastasis from renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Osteoclasts are required for bone tumors to grow and destroy bone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Bisphosphonates and metastatic breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Cytokine-activated endothelium recruits osteoclast precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

The molecular mechanism of osteoclastogenesis in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Efficacy of etanercept for wear debris-induced osteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Osteoclasts are essential for TNF-alpha-mediated joint destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Targeted etanercept for discogenic neck pain: uncontrolled, open-label results in two adults

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Etanercept reduces hyperalgesia in experimental painful neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Role of stromal-derived cytokines and growth factors in bone metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Antitumor effects of bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980219-9

7 January 2021

Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice

10

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(03)80219-9

Perispinal TNF-alpha inhibition for discogenic pain

14 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(03)80219-9

Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis

14 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(03)80219-9

14 March 2024

Identifiers

1 reference

11 September 2017

1 reference